Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze SPNT stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate SPNT investment potential.

What is SPNT stock price today?

Get real-time SPNT stock price, historical data, and price charts on Financhill. Track SPNT performance with our advanced analysis tools.

Is SPNT a good investment?

Evaluate SPNT investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy SPNT stock?

To buy SPNT stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of SPNT?

View detailed market capitalization data and company valuation metrics for SPNT on our comprehensive analysis page.

What is the P/E ratio of SPNT?

Use our fundamental analysis tools to view SPNT P/E ratio and compare valuation metrics with industry peers.

What are SPNT earnings?

View SPNT earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

SiriusPoint Ltd. 10K Form

Buy

SPNT
SiriusPoint Ltd.

Last Price:

$21.83

Seasonality Move:

-1.37%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2021-02-23	10K	SPNT/SiriusPoint Ltd. Annual
2020-11-05	10Q	SPNT/SiriusPoint Ltd. Quarterly
2020-08-10	10Q	SPNT/SiriusPoint Ltd. Quarterly
2020-05-07	10Q	SPNT/SiriusPoint Ltd. Quarterly
2020-02-28	10K	SPNT/SiriusPoint Ltd. Annual
2019-11-05	10Q	SPNT/SiriusPoint Ltd. Quarterly

Receive SPNT News And Ratings

See the #1 stock for the next 7 days that we like better than SPNT

SPNT Financial Statistics

Sales & Book Value

Annual Sales:	$2.6B
Cash Flow:	$155.1M
Price / Cash Flow:	18.7
Annual Sales:	$17.21
Price / Book:	1.24

Profitability

EPS (TTM):	1.58070
Net Income (TTM):	$199M
Gross Margin:	$0
Return on Equity:	9.06%
Return on Assets:	2.05%

SiriusPoint Ltd. Earnings Forecast

Key SiriusPoint Ltd. Financial Ratios

The Gross Profit Margin over the past 14 years for SPNT is 0.00%.
The Selling, General & Administrative Expenses for SPNT have been equal to 0.00% of Gross Profit Margin.
The Interest Expense is 34.39% of Operating Income.
The Net Earning history of SPNT is 7.77% of Total Revenues.
Per Share Earnings over the last 14 years have been positive in 6 years.

SiriusPoint Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSE
Industry:	Insurance
Sector:	Financials
Current Symbol:	SPNT
Website:	siriuspt.com

Debt

Debt-to-Equity Ratio:	0.32
Current Ratio:	0.68
Quick Ratio:	0

Price-to-Earnings

Trailing P/E Ratio:	20.52
Forward P/E Ratio:	8.74

SPNT Technical Analysis vs Fundamental Analysis

Buy

SiriusPoint Ltd. (SPNT) is a Buy

Is SiriusPoint Ltd. a Buy or a Sell?

SiriusPoint Ltd. stock is rated a Buy

The current SiriusPoint Ltd. [SPNT] share price is $21.33. The Score for SPNT is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.